These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11162550)

  • 21. Inhibition of osteoclast differentiation and bone resorption by a novel lysophosphatidylcholine derivative, SCOH.
    Kwak HB; Lee SW; Li YJ; Kim YA; Han SY; Jhon GJ; Kim HH; Lee ZH
    Biochem Pharmacol; 2004 Apr; 67(7):1239-48. PubMed ID: 15013839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of osteoclastogenesis by gap junction communication.
    Matemba SF; Lie A; Ransjö M
    J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.
    Urushibara M; Takayanagi H; Koga T; Kim S; Isobe M; Morishita Y; Nakagawa T; Löeffler M; Kodama T; Kurosawa H; Taniguchi T
    Arthritis Rheum; 2004 Mar; 50(3):794-804. PubMed ID: 15022321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.
    Yen ML; Tsai HF; Wu YY; Hwa HL; Lee BH; Hsu PN
    Mol Immunol; 2008 Apr; 45(8):2205-13. PubMed ID: 18206242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
    Uchiyama S; Yamaguchi M
    Biochem Pharmacol; 2004 Apr; 67(7):1297-305. PubMed ID: 15013845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand.
    Miyamoto T; Arai F; Ohneda O; Takagi K; Anderson DM; Suda T
    Blood; 2000 Dec; 96(13):4335-43. PubMed ID: 11110710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoclast development from hematopoietic stem cells: apparent divergence of the osteoclast lineage prior to macrophage commitment.
    Hayase Y; Muguruma Y; Lee MY
    Exp Hematol; 1997 Jan; 25(1):19-25. PubMed ID: 8989902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relaxin stimulates osteoclast differentiation and activation.
    Ferlin A; Pepe A; Facciolli A; Gianesello L; Foresta C
    Bone; 2010 Feb; 46(2):504-13. PubMed ID: 19833242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function.
    Lean JM; Fuller K; Chambers TJ
    Blood; 2001 Nov; 98(9):2707-13. PubMed ID: 11675341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-3-dependent hematopoietic stem cell lines capable of osteoclast formation in vitro.
    Hagenaars CE; Kawilarang-de Haas EW; van der Kraan AA; Spooncer E; Dexter TM; Nijweide PJ
    J Bone Miner Res; 1991 Sep; 6(9):947-54. PubMed ID: 1724106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloblastic cell line expresses osteoclastic properties following coculture with marrow stromal adipocytes.
    Benayahu D; Peled A; Zipori D
    J Cell Biochem; 1994 Nov; 56(3):374-84. PubMed ID: 7876331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential requirements for SCL/tal-1, GATA-2, macrophage colony-stimulating factor, and osteoclast differentiation factor/osteoprotegerin ligand in osteoclast development.
    Yamane T; Kunisada T; Yamazaki H; Nakano T; Orkin SH; Hayashi SI
    Exp Hematol; 2000 Jul; 28(7):833-40. PubMed ID: 10907645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells.
    Grigoriadis AE; Kennedy M; Bozec A; Brunton F; Stenbeck G; Park IH; Wagner EF; Keller GM
    Blood; 2010 Apr; 115(14):2769-76. PubMed ID: 20065292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stochastic differentiation into an osteoclast lineage from cloned macrophage-like cells.
    Hayashi S; Murata A; Okuyama K; Shimoda Y; Hikosaka M; Yasuda H; Yoshino M
    Biochem Biophys Res Commun; 2012 Nov; 428(2):303-8. PubMed ID: 23085228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro identification of a mononuclear precursor of osteoclast].
    Prallet B; Alexandre C; Baron R
    Rev Rhum Mal Osteoartic; 1991 Nov; 58(11):777-80. PubMed ID: 1780653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population.
    Scheven BA; Visser JW; Nijweide PJ
    Nature; 1986 May 1-7; 321(6065):79-81. PubMed ID: 3754620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor-beta1 (TGF-beta) stimulates the osteoclast-forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironment.
    Massey HM; Scopes J; Horton MA; Flanagan AM
    Bone; 2001 Jun; 28(6):577-82. PubMed ID: 11425644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The origin of the osteoclast.
    Hanaoka H; Yabe H; Bun H
    Clin Orthop Relat Res; 1989 Feb; (239):286-98. PubMed ID: 2912629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of osteoclast precursors in multilineage hemopoietic colonies.
    Hattersley G; Kerby JA; Chambers TJ
    Endocrinology; 1991 Jan; 128(1):259-62. PubMed ID: 1986920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD9 molecule expressed on stromal cells is involved in osteoclastogenesis.
    Tanio Y; Yamazaki H; Kunisada T; Miyake K; Hayashi SI
    Exp Hematol; 1999 May; 27(5):853-9. PubMed ID: 10340401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.